Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ω3 and ω6 PUFA in Acute on Chronic Liver Failure
NCT02691533Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of omega-3 polyunsaturated fatty acids and Intralipid 10% in liver failure, sponsored by Institute of Liver and Biliary Sciences. Started Feb 2016; status: completed.
02
Drugs
omega-3 polyunsaturated fatty acidsIntralipid 10%
03
Conditions
liver failure
Beyond the preview
Go deeper on NCT02691533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691533.